Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston
AstraZeneca at Discovery on Target 2026
Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website
AstraZeneca brings 9 presentations to Discovery on Target 2026 in Boston. Its program centres on radioligand therapies, from molecular design to personalized dosimetry, alongside antibody-drug conjugates and induced proximity. It also shows a 384-well proteomics method that tracks the fate of proteins under degrader control.
| Organization | Discovery on Target 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global biopharmaceutical company with medicines in oncology, cardiovascular, respiratory, immunology and rare diseases. | Chair Mon Sep 28 1:30pm–1:35pm Panel Tue Sep 29 11:05am–12:05pm Talk Tue Sep 29 1:50pm–2:20pm Talk Tue Sep 29 2:50pm–3:20pm Panel Tue Sep 29 5:00pm–6:00pm Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach Novel drug modalitiesInnovative discovery technologies Talk Wed Sep 30 9:05am–9:35am Talk Wed Sep 30 2:05pm–2:35pm Panel Wed Sep 30 3:05pm–4:05pm Panel Thu Oct 1 7:30am–8:15am |
Instantly find 20 buyers from AstraZeneca
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction